Day One Biopharmaceuticals
DAWN
DAWN
93 hedge funds and large institutions have $1.19B invested in Day One Biopharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 87 → 93 (+6)
0.14% more ownership
Funds ownership: 82.58% → 82.72% (+0.14%)
29% less call options, than puts
Call options by funds: $2.88M | Put options by funds: $4.07M
Holders
93
Holding in Top 10
5
Calls
$2.88M
Puts
$4.07M
Top Buyers
| 1 | +$39.4M | |
| 2 | +$33.7M | |
| 3 | +$15.2M | |
| 4 |
BlackRock
New York
|
+$11.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.1M |
Top Sellers
| 1 | -$54.1M | |
| 2 | -$49.7M | |
| 3 | -$16M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$9.95M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$5.99M |